Skip to content

Clinical trials

Completed Phase 1/2 Gliosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Phase: Phase 1/2 Status: Completed Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20013
20026
20031
20043
20055
20065
20074
20081
20093
20104
20123
20131
20142
20151
20161
20172
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
New Approaches to Brain Tumor Therapy Consortium7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins7
Alliance for Clinical Trials in Oncology3
Duke University3
Radiation Therapy Oncology Group3
Jonsson Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
BeiGene USA, Inc.1
Beth Israel Deaconess Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gliosarcoma59
Glioblastoma58
Brain Neoplasms39
Central Nervous System Neoplasms34
Astrocytoma28
Oligodendroglioma21
Glioma18
Medulloblastoma4
Meningioma4
Ependymoma3

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.